A new system can dial expression of synthetic genes up or down
The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.
The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.
Proposed system would combine two kinds of plants, creating greater efficiency and lowering costs while curbing climate-changing emissions.
MIT researchers developed a model that explains lithium intercalation rates in lithium-ion batteries.
MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders.
New findings could provide a way to monitor batteries for sounds that could guide manufacturing, indicate remaining usable life, or flag potential safety issues.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
System developed at MIT could provide realistic predictions for a wide variety of reactions, while maintaining real-world physical constraints.
Brushett leads one-of-its-kind program that has been a bridge between education and industry for over a century.
Solubility predictions could make it easier to design and synthesize new drugs, while minimizing the use of more hazardous solvents.
The Initiative for New Manufacturing is convening experts across the Institute to drive a transformation of production across the U.S. and the world.
New microparticles containing iron or iodine could be used to fortify food and beverages, to help fight malnutrition.
Researchers created polymers that are more resistant to tearing by incorporating stress-responsive molecules identified by a machine-learning model.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.
The platform identifies, mixes, and tests up to 700 new polymer blends a day for applications like protein stabilization, battery electrolytes, or drug-delivery materials.
The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.